More than half of patients with ischemic stroke experience futile reperfusion, increasing the risk of death and disabilities despite a successful recanalization. The reason behind this is debated, and ...

The mechanical and structural properties of actin cytoskeleton drive various cellular processes, including structural support of the plasma membrane and cellular motility. Actin monomers assemble into ...

Are you unsure whether Cipla Actin is actually the best option for your weight-gain requirements? It’s a worthwhile question to investigate. Losing weight can be difficult for some people, but ...

Umang Vohra to Nimura: "In the case of tariff barriers, generics companies are likely to be more selective, focusing on high-value opportunities including 'first to file'." The Managing Director ...

Cipla has recently fallen below its 20-day Exponential Moving Average, currently standing at a price of Rs 1460.3. Today, it has experienced a change of -1.11%, with the 20-day EMA noted at 1460.34.

Mumbai: Pharma major, Cipla, has received final approval from the United States Food and Drug Administration (USFDA) for the New Drug Application (‘NDA’) submitted for ‘Nilotinib Capsules 50, 150 and ...

The National Stock Exchange has decided to remove Berger Paints from the Futures & Options segment, effective April 25. Existing unexpired contracts for the expiry months of February, March, and ...

Lupin Ltd., Cipla Ltd., Sun Pharmaceutical Industries Ltd., and Zydus Lidesciences Ltd. delivered strong revenue and profit growth in the December quarter, beating analyst expectations, and are the ...

Explore Cipla stock price history with detailed daily historical prices, including open, high, low, and volume data. Review stock chart history to analyze past trends and find the highest Cipla price.